NRX Pharmaceuticals publishes update to financial calendar

NRXP•2026-11-12

NRx Pharmaceuticals will release third-quarter 2026 results before the market opens on Nov. 17, with a conference call scheduled for 8 a.m. ET that day.

1. Results and call scheduled

NRx Pharmaceuticals will release its third-quarter 2026 financial results before the market opens on Nov. 17, 2026. A conference call covering the results and a corporate update is scheduled for 8 a.m. ET that day.

NRX Pharmaceuticals publishes update to financial calendar

1. Results and call scheduled

Related News

HireQuest's Q3 net income falls on write-down impact

CapsoVision appoints David S. Shields to board of directors

Equifax EVP, Chief Technology Officer Jamil Farshchi reports sale of $2.87 million in common shares

Pliant Therapeutics presents RNA delivery platform targeting skeletal and cardiac muscle

Accelevation Q3 2026 net income drops 77% year over year to $3.2 million